Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SGMO

Sangamo Therapeutics Inc

May 01 • 10:45AM ET

0.1267

+0.0075 6.29 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: GILD CRSP NTLA BMRN EDIT QURE BLUE KYNB VYGR VXRT

| Held by: VTI VXF SCHA PRFZ ITOT XDNA GNOM SCHB QQQS BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	1.02%	Shs Outstand	414.27M	Perf Week	-33.35%
Market Cap	52.49M	Forward P/E	-	EPS next Y	-0.06	Insider Trans	-8.96%	Shs Float	410.06M	Perf Month	-51.29%
Enterprise Value	58.34M	PEG	-	EPS next Q	0.01	Inst Own	14.95%	Short Float	10.46%	Perf Quarter	-76.34%
Income	-122.93M	P/S	1.33	EPS this Y	56.82%	Inst Trans	-0.28%	Short Ratio	5.43	Perf Half Y	-78.16%
Sales	39.55M	P/B	-	EPS next Y	71.05%	ROA	-148.26%	Short Interest	42.88M	Perf YTD	-69.83%
Book/sh	-0.04	P/C	2.51	EPS next 5Y	-	ROE	-2891.84%	52W High	0.79 -83.90%	Perf Year	-82.91%
Cash/sh	0.05	P/FCF	-	EPS past 3/5Y	29.38% 13.38%	ROIC	-1135.63%	52W Low	0.12 9.70%	Perf 3Y	-91.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-29.17% -19.66%	Gross Margin	80.78%	Volatility	30.00% 16.27%	Perf 5Y	-98.92%
Dividend TTM	-	EV/Sales	1.48	EPS Y/Y TTM	14.22%	Oper. Margin	-273.07%	ATR (14)	0.04	Perf 10Y	-97.99%
Dividend Ex-Date	-	Quick Ratio	0.84	Sales Y/Y TTM	-31.57%	Profit Margin	-310.81%	RSI (14)	25.09	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.84	EPS Q/Q	0.45%	SMA20	-45.42%	Beta	1.04	Target Price	3.75
Payout	-	Debt/Eq	-	Sales Q/Q	88.43%	SMA50	-59.91%	Rel Volume	3.19	Prev Close	0.12
Employees	142	LT Debt/Eq	-	Earnings	Mar 30 AMC	SMA200	-72.55%	Avg Volume	7.90M	Price	0.13
IPO	Apr 06, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1322.22% -64.63%	Trades		Volume	5,873,109	Change	6.29%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)